Subcutaneous ocrelizumab (SC OCR) was found to be safe for patients with relapsing and primary progressive multiple sclerosis ...

Data from a systematic review of 30 real-world studies show comparable discontinuation rates of ocrelizumab to those in ...

"The EDSS has a number of limitations and may also measure changes that are not related to MS, such as older age and multiple ...

Background Treatment options for patients suffering from progressive forms of multiple sclerosis (MS) remain inadequate. Mast cells actively participate in the pathogenesis of MS, in part because ...

Contineum Therapeutics has concluded the targeted enrolment of 168 subjects in its Phase II trial of M1 receptor antagonist ...

Combination therapy with modafinil and CBT was as effective as modafinil monotherapy or CBT alone in the treatment of MS-related fatigue at 12 weeks.

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

A lawsuit filed against Denise Richards' husband Aaron Phypers alleged that he made a verbal agreement to return 50% of the ...

If you have multiple sclerosis (MS) and are hoping to get pregnant, the news is good: MS itself does not make a pregnancy ...

In an Ideas piece, Megan Giller asked why disability stories seem to have only one of two endings. Her essay drew reaction ...

An interim government headed by Nobel Peace Prize laureate Muhammad Yunus is running the country following the ousting of ...